Blood pressure variability ratio (BPVR)(derived from within-subject SD of 24-hour ambulatory blood pressure [BP]) predicts all-cause mortality independent of BP and has a similar prognostic ability to ambulatory arterial stiffness (AASI). Whether BPVR, and AASI, offer prognostic information beyond measurements of arterial stiffness at a given pressure, as indexed by pulse wave velocity (PWV), is not known.
Indexes of arterial stiffness derived from pulse wave analysis (pulse wave velocity [PWV] and augmentation index [AI]) predict cardiovascular outcomes [1] [2] [3] and target organ changes [4] [5] [6] independent of blood pressure (BP) and other confounders. However, the measurement of arterial stiffness using pulse wave analysis requires dedicated instrumentation, which is generally unavailable in daily clinical practice. Nevertheless, the ambulatory arterial stiffness index (AASI), derived from 1 minus the slope of the standard linear relationship between diastolic and systolic BP values obtained from 24-hour BP monitoring, has also been shown to predict cardiovascular outcomes [7] [8] [9] and target organ damage 10, 11 independent of BP. The convenience of 24-hour ambulatory BP monitoring has therefore aroused great interest in the value of AASI as a potential prognostic marker. 12 Moreover, as AASI is a marker for the tendency of arteries to become stiffer during systole (arterial stiffening), AASI may provide prognostic information beyond PWV (a measure of arterial stiffness at a given pressure). 13 Indeed, the bivariate correlation coefficients between PWV and AASI at most approximate 0.51, 14 but could be as low as 0.12, 15 and after adjustments for covariates may fail to achieve significance. [15] [16] [17] However, as AASI is determined by factors other than arterial stiffening, including BP "dipping" and the correlation between systolic and diastolic BP data (data scattering), 18 the relationship between AASI and adverse cardiovascular changes could be attributed to these confounding factors. 18, 19 The blood pressure variability ratio (BPVR, defined as the ratio between SD of systolic BP and SD of diastolic BP), is a novel index of arterial stiffening that is insensitive to these confounding
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factors, predicts all-cause mortality independent of BP and has a similar prognostic ability to AASI. 20 Although, BPVR is a measure of arterial stiffening (more precisely, BPVR estimates the relative increase in stiffness during systole), as opposed to arterial stiffness, 13 whether BPVR offers prognostic information beyond PWV, is not known. In this regard, 2 recent studies 21, 22 have reported antihypertensive medication-induced reductions in PWV, in the absence of analogous changes in AASI, supporting the concept that AASI and PWV provide different information on the properties of large arteries. However, no direct comparisons have previously been made between the ability of measures of arterial stiffening (BPVR, AASI) and stiffness (PWV) to predict cardiovascular damage. We hypothesized that measures of arterial stiffening offer prognostic information beyond PWV, a measure of arterial stiffness. Hence, in the present study, we compared the relationships between BPVR, AASI vs. PWV and target organ measures and evaluated the extent to which adjustments for PWV influence the relations between BPVR and AASI and subclinical target organ effects.
METHODS

Study group
The present study was approved by the Committee for Research on Human Subjects of the University of the Witwatersrand (approval number: M02-04-72, renewed as M07-04-69 and M12-04-108). Participants gave informed, written consent. The study design and the population sampled has previously been described. 4, [23] [24] [25] [26] [27] [28] Briefly, 1,197 participants older than 16 years of age from nuclear families of Black African ancestry (Nguni and Sotho chiefdoms) were randomly recruited from the South West Township (SOWETO) of Johannesburg, South Africa using the population census figures of 2001. Of these participants, 772 had 24-hour ambulatory BP monitoring that met with the European Society of Hypertension (ESH) guidelines (longer than 14 and 7 readings for the computation of day and night means, respectively), 29 and glomerular filtration rate (GFR) estimated using standard formulae (eGFR), and 677 had aortic PWV. In a series of substudies in this cohort (n = 772), 539 had left ventricular mass index (LVMI) and early-to-late transmitral flow velocity (E/A), and 392 had carotid intima-media thickness (IMT) determined.
Clinical, demographic, and anthropometric measurements
A standardized questionnaire was administered to obtain demographic and clinical data as previously described. 4, [23] [24] [25] [26] [27] [28] Conventional BP was determined from the mean of 5 nurse-derived BP measurements obtained with a mercury sphygmomanometer as previously described. 26 From height and weight measurements, body mass index was calculated and participants were identified as being overweight if their body mass index was ≥25 kg/m 2 and obese if their body mass index was ≥30 kg/m 2 . Waist circumference was assessed using a standard approach. Blood lipid profiles and percentage glycated hemoglobin (HbA 1c ) were determined. Diabetes mellitus or abnormal blood glucose control was defined as the use of insulin or oral hypoglycemic agents or an HbA 1C value greater than 6.1%. 30 Participants were classified as hypertensive if they were receiving antihypertensive therapy or if conventional BP values were ≥140/90 mm Hg.
Ambulatory BP, AASI, and BPVR
Twenty-four-hour ambulatory BP monitoring was performed using oscillometric monitors (SpaceLabs, model 90207) as previously described. 26, 28 The size of the cuff was the same as that used for conventional BP measurements. Monitors were programmed to measure 24-hour BP at 15-minute intervals from 06:00 to 22:00 hours and at 30-minute intervals from 22:00 to 06:00 hours. Fixed-clock time periods rather than actual in bed and out of bed periods were statistically analyzed to ensure that similar day and night-time periods were selected for comparisons between individuals. Day and night periods ranged from 09:00 to 19:00 hours and from 23:00 to 05:00 hours, respectively. Intraindividual means of the ambulatory measurements were weighted by the time interval between successive readings. The average (±SD) number of BP readings obtained was 60.5 ± 12.2 (range = 24-81) for the 24-hour period, 28.9 ± 6.7 (range = 14-41) for the day and 9.5 ± 0.8 (range = 7-11) for the night periods. Systolic and diastolic BP dipping were calculated for each participant as 1-(night/day BP ratio) expressed as a percentage.
AASI was calculated from each participant's ambulatory BP values using previously described methods. [7] [8] [9] [10] [11] 14, 17 Briefly, the slope (β-coefficient) of the regression relationship between diastolic and systolic BP for all available BP recordings was obtained and AASI calculated as 1-the slope of the relationship. As symmetrical regression has been suggested to provide a more valid estimate of AASI, (less influenced by goodness of fit and nocturnal dipping of BP than AASI), 18 we also calculated symmetric AASI (sym-AASI) as 1 − (1/B), 18 where B is the slope obtained by symmetric regression of systolic vs. diastolic BP. It is noteworthy that AASI equals 1 − R/B, where R is the systolic-diastolic correlation coefficient. 18 One convenient expression of the slope B using symmetric regression is the ratio of within-participant SD of systolic BP to SD of diastolic BP over a 24-hour period called the BPVR. 20 Therefore, the determination of both BPVR and sym-AASI defined as 1 − 1/BPVR 20 do not require regression analysis. The within-participant coefficient of variation of systolic and diastolic BP over a 24-hour period, and the within-participant SD of systolic BP and diastolic BP over a 24-hour period were used as indexes of BP variability. 31 
Pulse wave analysis
On the same day as ambulatory BP monitoring was performed, aortic (carotid-femoral) PWV and central aortic BP were estimated using radial, carotid, and femoral applanation tonomtery (high-fidelity SPC-301 micromanometer, Millar Instrument, Houston, TX) interfaced with a computer employing SphygmoCor, version 9.0 software (AtCor Medical Pty, West Ryde, New South Wales, Australia) as described previously, 4, 23, 25, 26 and in the Online Supplementary data. The aortic backward (reflected) (Pb) wave pressure was determined from the aortic pulse wave using SphygmoCor software which separates the aortic waveform using a triangular flow wave.
End-organ measures-LVMI
Echocardiographic measurements were recorded and analysed offline by experienced investigators who were unaware of the clinical data of the participants and whom had a low degree of interobserver and intraobserver variability. 32 LVMI was determined from transthoracic 2-dimensional targeted M-mode echocardiography with the participants in the partial left decubitus position, as previously described. 26, 32 Echocardiography recordings were analyzed according to the American Society of Echocardiography convention. 33 Left ventricular mass was determined using a standard formula 34 and indexed (LVMI) to height 1.7 . Left ventricular hypertrophy was identified as LVMI >80 g/m 1.7 for men and >60 g/m 1.7 for women. 35 
Early-to-late transmitral flow velocity
Left ventricular early-to-late transmitral flow velocity (E/A) was assessed from a pulsed wave Doppler examination of the mitral inflow at rest. 36 
Estimated GFR
Serum creatinine concentrations were measured using the Advia Chemistry systems (Siemens) with calibration traceable to isotope dilution mass spectrometry (IDMS). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and the 4-variable Modification of Diet in Renal Disease (MDRD) were employed to estimate GFR. The ethnicity factor as recommended in African Americans when calculating the MDRD and CKD-EPI was not applied in the present study as the use results in overestimation of kidney function in Black Africans in the present region. 37, 38 A decreased eGFR was identified as <90 ml/min/1.73 m2 (CKD stage 2) or <60 ml/min/1.73 m2 (CKD stage 3).
Carotid intima-media thickness
Carotid IMT was determined using high-resolution B-mode ultrasound (SonoCalc IMT, Sonosite, Bothell, WA) employing a linear array 7.5 MHz probe as previously described. 32 An increased IMT was identified as >0.90 mm. 39 
Data analysis
For database management and statistical analysis, SAS software, version 9.3 (SAS Institute, Cary, NC) was employed. Data are shown as mean ± SD. Multivariate-adjusted linear (continuous data) or logistic (discrete data) regression analysis was performed to determine independent relations. Potential confounders were identified on bivariate relationships with indexes of arterial stiffening, stiffness, or TOD. In multivariate analyses, adjustments were made for age, sex, regular smoking, regular alcohol consumption, diabetes mellitus and/or HbA 1c >6.1%, treatment for hypertension, total cholesterol, and 24-hour mean BP. To determine whether AASI and BPVR vs. TOD relations were independent of BP variability and BP dipping, further adjustments were made for coefficients of variation of systolic and diastolic BP, SDs of systolic and diastolic BP, and day minus night BP, respectively. To determine whether AASI and BPVR provided information beyond measures of arterial stiffness, AASI and BPVR-TOD relations were further adjusted for PWV. Correlation coefficients were compared using Fisher's Z transformation. Table 1 gives the characteristics of the study group and the cohorts with either high-quality echocardiograms or carotid IMT. Participants with high-quality echocardiographic data or carotid IMT had similar characteristics to the whole study group. In the cohort with echocardiographic data, 250 participants (46.4%) had left ventricular hypertrophy, and in the cohort with carotid IMT, 13 participants (3.3%) had IMT >0.9 mm. Comparisons between the characteristics of those included and those not included in the study are shown in the Online Supplementary data (Supplementary Tables S1-S3).
RESULTS
Characteristics of the participants
Comparisons of relationships of indexes of arterial stiffening and stiffness with BP variables, heart rate, and age
The relationships between indexes of arterial stiffening and BP variables as well as between PWV and BP variables are shown in Table 2 . AASI was strongly associated with the slope of the systolic-diastolic BP relation (Table 2) . Although, sym-AASI and BPVR were also associated with the slope of the systolic-diastolic BP relation (Table 2) , these associations were weak, and indeed the magnitude of these relations were significantly lower than that of AASI (P < 0.0001 for comparison of r values). AASI and BPVR, but not sym-AASI, were correlated with systolic BP dipping (Table 2) . However, the strength of the relationship with BPVR was lower than that for AASI (P < 0.0001 for comparison of r values). AASI, sym-AASI and BPVR were negatively correlated with DBP dipping; however, the strength of the relationships with sym-AASI and BPVR were lower than that for AASI (P < 0.0005 for comparison of r values). In addition, AASI (r = 0.40), sym-AASI (r = 0.42), and BPVR (r = 0.45) were associated with age (all P < 0.0001), but not with heart rate (P > 0.37). In comparison, PWV showed stronger relationships with white-coat effects, aortic pulse pressure, and reflected wave magnitude than either sym-AASI or BPVR. In addition, PWV was more strongly related to age (r = 0.66, P < 0.0001) than either sym-AASI or BPVR (P < 0.0001 for comparison with relations between sym-AASI or BPVR and age) and was significantly related to heart rate (r = 0.13, P < 0.001).
Relationships between indexes of arterial stiffening and stiffness
On bivariate analysis, AASI (r = 0.36, P < 0.0001), sym-AASI (r = 0.36, P < 0.0001), and BPVR (r = 0.39, P < 0.0001) were correlated with PWV. However, no relationships were noted on multivariate analysis: PWV and AASI (r = 0.05, P = 0.22), PWV and sym-AASI (r = 0.05, P = 0.18), and PWV and BPVR (r = 0.06, P = 0.15).
Independent relationships between AASI, sym-AASI, BPVR, and PWV with target organ measures
The bivariate correlations between AASI, sym-AASI, BPVR, PWV, indices of BP dipping, and indices of BP variability and target organ measures are described in the Online Supplementary data (Supplementary Table S4 ). Table 3 shows the multivariate relationships between AASI, sym-AASI, BPVR, and PWV and target organ measures. After adjusting for confounders (excluding 24-hour mean BP), sym-AASI, BPVR, and PWV but not AASI remained independently related to eGFR. No independent relationships were noted between AASI, sym-AASI, BPVR or PWV and LVMI, E/A or IMT after adjusting for confounders.
Impact of further adjustments for hemodynamic variables on the independent relationships between AASI, sym-AASI, BPVR, and PWV with eGFR of various hemodynamic variables as adjustors. Sym-AASI, BPVR, and PWV, but not AASI, were independently related to eGFR. After further adjustments for the coefficient of variation of systolic BP or diastolic BP, sym-AASI and BPVR remained independently related to eGFR (Figure 1b and c) .
Similarly, after further adjustments for systolic or diastolic BP dipping, sym-AASI and BPVR remained independently related to eGFR (Figure 1b and c) . Importantly, the independent relationships between sym-AASI and BPVR and eGFR were unaltered by the inclusion of PWV as an adjustor *P < 0.05, **P < 0.0005, ***P < 0.0001 vs. correlation with AASI; † P < 0.0005, † † P < 0.0001 vs. correlation with PWV. Abbreviations: AASI, ambulatory arterial stiffness index; BPVR, blood pressure variability ratio; CVDBP24, coefficient of variation of 24hour DBP; CVSBP24, coefficient of variation of 24hour SBP; DBP, diastolic blood pressure; DBPdipp, nocturnal dipping in DBP; Pb, backward wave pressure; PPc, central aortic pulse pressure; PWV, pulse wave velocity; r, correlation coefficient; r of SBP vs DBP, correlation coefficient of relationship between SBP and DBP; SBP, systolic blood pressure; ; SBPdipp, nocturnal dipping in SBP; SDDBP24, SD of 24hour DBP; SDSBP24, SD of 24hour SBP; sym-AASI, symmetrical ambulatory arterial stiffness index. Abbreviations: AASI, ambulatory arterial stiffness index; BPVR, blood pressure variability ratio; E/A, early-to-late transmitral velocity; eGFR-CKD, estimated glomerular filtration rate calculated using Chronic Kidney Disease Epidemiology Collaboration equation; eGFR-MDRD, estimated glomerular filtration calculated using the Modification of Diet in Renal Disease equation; IMT, intima-media thickness; LVMI, left ventricular mass index; PWV, pulse wave velocity; sym-AASI, symmetrical ambulatory arterial stiffness index.
a Adjusted for age, sex, body mass index (body weight for LVMI), regular smoking, regular alcohol consumption, treatment for hypertension, diabetes mellitus, or an increased glycated hemoglobin (HbA 1c > 6.1%) and total cholesterol. (Figure 1b and c) . Similarly, adjustments for central aortic pulse pressure or the magnitude of the reflected wave had no impact on the independent relationships between sym-AASI and BPVR and eGFR (Figure 1b and c) . PWV was independently associated with eGFR with and without adjustments for various hemodynamic factors. Importantly, the inclusion of AASI, sym-AASI, or BPVR as an adjustor had no impact on the independent relationship between PWV and eGFR ( Figure 1d ). When eGFR-MDRD was assessed, similar relationships were observed (data not shown). Figure 2 shows the multivariate-adjusted mean eGFR-CKD per quartile of sym-AASI, BPVR, and PWV. Mean eGFR-CKD was lower in the highest quartiles compared to the lowest quartile of sym-AASI (Figure 2a ) and lower in the highest 2 quartiles compared to the lowest quartile of BPVR (Figure 2c) . Figure 2b and d shows the impact of further adjustment for PWV on the multivariate-adjusted mean eGFR-CKD per quartile of sym-AASI and BPVR. Further adjustment for PWV had no impact on the differences in eGFR-CKD observed in the higher quartiles compared to the lowest quartile of sym-AASI and BPVR. Similarly, eGFR-CKD was lower in the higher quartiles compared to the lowest quartile of PWV (Figure 2e) , and the further adjustment for sym-AASI (Figure 2f ) or BPVR (Figure 2g ) had no impact on the multivariate-adjusted mean eGFR-CKD per quartile of PWV.
Impact of adjustments for PWV on eGFR per quartile of sym-AASI and BPVR
Interactive effects of PWV and indexes of arterial stiffening on eGFR
After adjusting for confounders, no interactive effects between PWV and BPVR on eGFR were noted (r = 0.02, P = 0.70). Hence, eGFR decreased across quartiles of BPVR in participants with PWV below the median (Figure 3a) as well as in participants with PWV above the median (Figure 3b) . eGFR also decreased across quartiles of PWV in participants with BPVR below the median (Figure 3c ) as well as in participants with BPVR above the median (Figure 3d) . Similarly, no interactive effects between PWV and either AASI (r = 0.04, P = 0.31) or sym-AASI (r = 0.06, P = 0.15) on eGFR were noted.
Impact of adjustments for PWV on ability of sym-AASI and BPVR to predict decreased eGFR
To estimate the accuracy of sym-AASI, BPVR, and PWV to predict the presence of a reduced eGFR-CKD, we performed multivariate logistic regression analysis. BPVR and PWV, but neither AASI nor sym-AASI were associated with a reduced eGFR (Figure 4) . Importantly, further adjustments for PWV had no impact on the relationship between BPVR and a reduced eGFR (Figure 4) . Similarly, further adjustments for BPVR had no impact on the relationship between PWV and a reduced eGFR (Figure 4) . b and d) . The impact of further adjustment for sym-AASI or BPVR on the multivariate-adjusted mean eGFR-CKD per quartile of PWV is shown in panels f and g, respectively. Adjustments are for age, sex, regular smoking, regular alcohol consumption, diabetes mellitus and/or HbA 1c >6.1%, treatment for hypertension, total cholesterol, and 24-hour mean BP. *P < 0.05, **P < 0.005, ***P < 0.0005 vs. quartile 1; † P < 0.05 vs. quartile 2. Abbreviations: BPVR, blood pressure variability ratio; eGFR-CKD, estimated glomerular filtration rate calculated using Chronic Kidney Disease Epidemiology Collaboration equation; HbA 1c , glycosylated hemoglobin; PWV, pulse wave velocity; sym-AASI, symmetrical ambulatory arterial stiffness index.
DISCUSSION
The main findings of the present study are as follows: In a community population sample, BPVR, sym-AASI and PWV, but not AASI, showed associations with eGFR independent of confounders and various BP variables including systolic and diastolic BP dipping. Moreover, after further adjustments for PWV, the residual relationships between BPVR or sym-AASI and eGFR were almost identical to those noted before adjustments for PWV. Similarly, no interactive effects between PWV and BPVR or sym-AASI on eGFR were noted. Hence, indexes of arterial stiffening provide information on eGFR beyond an index of arterial stiffness.
Although there is evidence to indicate that BPVR 20 and sym-AASI 19, 20 predict cardiovascular outcomes and target organ changes independent of confounders, 40 and to a greater extent than AASI, there is still uncertainty as to whether BPVR and sym-AASI (indexes of arterial stiffening) provide prognostic information beyond the gold standard noninvasive index of arterial stiffness, PWV. 17 In this regard, 2 recent studies have reported antihypertensive medicationinduced reductions in PWV, in the absence of any changes in AASI or sym-AASI. 21, 22 These discrepant responses to antihypertensive therapy would suggest that AASI and sym-AASI are likely to provide different information from PWV on the properties of large arteries. In addition, AASI and PWV are reported to predict outcomes independent of each other. 9 In this regard, AASI predicts stroke independent of PWV, and PWV predicts composite cardiovascular events independent of AASI. 9 The inability of PWV to modify the independent relationships between sym-AASI and eGFR, Figure 3 . Estimated glomerular filtration rate (eGFR-CKD) across quartiles of BPVR in participants with PWV below the median (a) and in participants with PWV above the median (b), and across quartiles of pulse wave velocity (PWV) in participants with BPVR below the median (c) and in participants with BPVR above the median (d). Adjustments are for age, sex, regular smoking, regular alcohol consumption, diabetes mellitus and/or HbA 1c >6.1%, treatment for hypertension, total cholesterol, and 24-hour mean BP. *P < 0.05, **P < 0.01, ***P < 0.001 vs. quartile 1; † P < 0.05, † † P < 0.01 vs. quartile 2. Abbreviations: BPVR, blood pressure variability ratio; eGFR-CKD, estimated glomerular filtration rate calculated using Chronic Kidney Disease Epidemiology Collaboration equation; HbA 1c , glycosylated hemoglobin; PWV, pulse wave velocity. and the lack of interactive effects between sym-AASI and PWV on eGFR in the present study, support these previous data and suggest that sym-AASI and PWV provide different information on the impact of changes in arterial properties on eGFR. Moreover, in the present study, which is the first to compare BPVR and PWV, the inability of PWV to modify the independent relationships between BPVR and eGFR, and the lack of interactive effects between BPVR and PWV on eGFR, suggest that BPVR like sym-AASI also provides information beyond PWV for TOD and hence possibly for outcomes. Importantly, information provided by measures of arterial stiffness is limited by the pressure-dependence of these measures, whereas measures of arterial stiffening provide largely pressure-independent information on the behavior of large arteries. 13 Few previous studies have compared BP-independent relationships between sym-AASI and TOD to relationships between AASI and TOD. 40 Moreover, although BPVR has been reported to impact on outcomes, 19, 20 the present study is the first to report on BPVR-TOD relationships. In support of the relationships observed between eGFR and sym-AASI but not AASI, a previous study in hypertensive and renal patients similarly reported independent relations between sym-AASI and eGFR, but not between AASI and eGFR after adjustments for 24-hour BP and BP dipping. 40 In this regard, AASI has been criticized, as unlike sym-AASI, AASI is strongly determined by the correlation between the systolic and diastolic BP, and BP dipping. 17, 18 Similarly, the strength of the bivariate relationships between AASI and BP dipping were greater than those for either sym-AASI or BPVR. Moreover, in the present study, the multivariate relationships between sym-AASI or BPVR and eGFR were not altered by further adjustments for BP dipping. In comparison, AASI-creatinine clearance and AASI-albumin to creatinine ratio relationships were abolished by adjustment for BP dipping. 40 Hence, relationships between AASI and measurements of renal function as reported in some previous studies, 10, 11 where no adjustments for BP dipping were made, are likely to reflect the effects of BP dipping. In this regard, the present study supports the notion that sym-AASI and BPVR are preferable to AASI in predicting outcomes. 19, 20 Few previous studies have reported on relationships between AASI or sym-AASI and LVMI or IMT, and no previous study has reported on relationships with E/A. With respect to AASI, those studies reporting significant AASI-LVMI or AASI-IMT associations, failed to adjust for BP variables including mean BP and BP dipping. 10, 41 Indeed, Schillaci et al. 17 reported that AASI was not associated with LVMI after adjustments including BP dipping. Only one previous study has assessed relationships between sym-AASI and LVMI or IMT. 41 In agreement with our study, no relationships between sym-AASI and LVMI were observed, and sym-AASI was only weakly correlated with IMT before adjustments for any BP variables. 41 Although no previous study has simultaneously assessed the relationships between various indices of TOD and sym-AASI, the data in the present study showing that LVMI, E/A, and IMT were not independently related to sym-AASI (or BPVR), appear to support the separate findings of prior studies. 17, 41 The reasons for the relationships between sym-AASI, BPVR or PWV and eGFR, but not other TOD are not readily apparent. It has previously been suggested that the kidneys are particularly prone to the effects of pulsatile blood flow, more than other TOD such as the heart. 42 Hence, it is possible that measures of both arterial stiffness and stiffening reflect increases in the pulsatility of blood flow. Nevertheless, further explanations for the sym-AASI, BPVR, or PWVeGFR but no other end-organ relationships are still required.
Some explanation of the differences between measures of arterial stiffening (sym-AASI and BPVR) and arterial stiffness (PWV) is required. In this regard, it has been suggested that sym-AASI and BPVR are composite indices reflecting an integration of arterial structural and functional properties. As the slope of systolic vs. diastolic BP values is typically greater than unity, this indicates a greater variation in BP during systole compared to during diastole. The greater variation in BP during systole is thought to reflect greater increases in arterial stiffness in systole relative to diastole. 18, 43 Indeed, a steeper slope has been observed in hypertensives compared to normotensives, which is thought to indicate hypertension-induced chances in arterial structure. 43 In addition, differential responses of systolic compared to diastolic BP to pressor effects have been observed. In this regard, in young patients, diastolic BP responses to the cold pressor test were greater than systolic BP responses. 44 Conversely, in elderly patients, the cold pressor test elicited greater responses in systolic than diastolic BP. 44 In addition to age, baseline BP was associated with greater SBP responses to the cold pressor test. 44 Thus, a greater variation of systolic compared to diastolic BP over a 24-hour period, as indexed by BPVR, is likely to reflect an integration of arterial structural and functional properties. Indeed, sym-AASI and BPVR provide information about the dynamic behavior of arteries (arterial stiffening) over a range of changes in stiffness and pressure; which is not adequately captured by PWV (a measure of arterial stiffness at a given pressure and volume). 13 The present data are of clinical importance as they indicate that BPVR-eGFR relations are analogous to sym-AASI-eGFR relations. This is expected due to the fact that sym-AASI can be obtained from BPVR and vice versa (sym-AASI equals 1 − 1/BPVR), where BPVR is determined simply from ambulatory BP reports by the ratio of the SD of systolic BP to the SD of diastolic BP. However, the sensitivity of sym-AASI to BPVR decreases as BPVR increases. For example, if BPVR increases from 1.5 to 1.6, i.e., by 0.100, the corresponding change in sym-AASI is (1 − 1/1.5) − (1 − 1/1.6) = 0.042. This may explain the higher partial correlation of eGFR-CKD vs. BPVR than vs. sym-AASI shown in Figure 1 , as evidence that eGFR-CKD is associated with the ratio of systolic and diastolic BP variability. Furthermore, as the impact of BPVR on eGFR is independent of BP effects, including BP dipping and white-coat effects, the present study supports the use of BPVR as a simple BP-independent parameter in the prediction of TOD and short-term mortality. 20 Moreover, BPVR and sym-AASI provide information beyond PWV on the impact of changes in arterial properties on eGFR. However, further investigations are required to determine whether sym-AASI and BPVR provide information on cardiovascular risk beyond eGFR.
The limitations of the present study are the cross-sectional, rather than prospective nature of the study design and the lack of outcomes data. In this regard, further prospective studies are required to evaluate whether the impact of sym-AASI and BPVR on TOD is a causal effect. However, previous outcomes data indicate the superiority of sym-AASI over AASI and the similarity of BPVR to sym-AASI in predicting outcomes. 20 Secondly, as the data were collected in a population consisting predominantly of women, it is possible that the results of the present study pertain primarily to women. As the current data were collected in a cross-sectional population (45% hypertensive) of participants of Black African ancestry, and previous data with sym-AASI were collected in hypertensive and renal patients from Spain, 40 it is unlikely that these data pertain only to hypertensives or to participants of Black African ancestry.
In conclusion, the results of the present study suggest that BPVR which is easily accessible from 24-hour ambulatory BP reports can be used to assess the relationship between arterial stiffening and renal function. Moreover, the data suggest that sym-AASI and BPVR as measures of arterial stiffening provide information beyond PWV, a measure of arterial stiffness. Hence, changes in both arterial stiffening and stiffness contribute to alterations in renal function. Further studies are, however, required to assess whether the impact of BPVR on outcomes as previously reported, is independent of the impact of PWV on outcomes.
